Axcelis Technologies Reports Q1 Beat, Strong Memory Demand, and Positive Q2 Outlook
ACLS has more than doubled off its 52-week low of $55.81.
Summary
Axcelis Technologies reported better-than-expected Q1 2026 financial results, driven by strong demand in memory, and issued positive guidance for Q2 2026.
Key Events · Earnings and Guidance · ACLS
-
Q1 2026 Financial Results Exceed Estimates
Axcelis Technologies reported Q1 2026 revenue of $199.0 million and non-GAAP diluted earnings per share of $0.72, both surpassing analyst expectations.
-
Strong Q2 2026 Guidance Issued
The company provided Q2 2026 guidance, expecting revenues of approximately $205 million and non-GAAP diluted earnings per share of approximately $0.90, indicating sequential growth.
-
Operational Strength in Memory and CS&I
Management highlighted strong sequential growth in DRAM and HBM demand, along with the continued strength of its CS&I (Customer Service & Support) business.
-
Robust Balance Sheet and Cash Flow
Axcelis ended Q1 with approximately $570 million in cash and continued to generate attractive free cash flow, supporting growth objectives and capital allocation.
Analysis · ACLS · Technology
Axcelis Technologies announced first-quarter 2026 financial results that surpassed analyst estimates, driven by strong performance in its CS&I business and significant acceleration in the Memory segment, particularly in DRAM and HBM. The company reported Q1 revenue of $199.0 million and non-GAAP diluted EPS of $0.72. Management provided an optimistic outlook for the second quarter, projecting revenues of approximately $205 million and non-GAAP diluted EPS of $0.90, indicating sequential growth. The company also highlighted its strong balance sheet with approximately $570 million in cash and continued free cash flow generation, providing financial flexibility. The reiteration of the Veeco merger closing in the second half of 2026 provides ongoing strategic context.
At the time of this filing, ACLS was trading at $155.67 on NASDAQ in the Technology sector, with a market capitalization of approximately $4.9B. The 52-week trading range was $55.81 to $171.61. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.